Nationality: Dutch
Position: Intensivist, Spaarne Gasthuis, Amsterdam, The Netherlands; and Senior Scientist, Erasmus MC, Rotterdam, The Netherlands
Research fields: Special interest in acute care and infectious diseases
ESWI member since 2016
Marco Goeijenbier completed his Ph.D. in virology, focusing on "Haemostasis and Virus Infection," at Erasmus University Rotterdam in 2015. He currently serves as a specialist in acute internal medicine and critical care at Spaarne Hospital in Haarlem, The Netherlands. His expertise spans various aspects of infectious diseases, particularly in critical care medicine and viral infections. In addition to his clinical work, Goeijenbier holds a research position at Erasmus MC in Rotterdam, where he mentors PhD students exploring critical care medicine and viral infections. His research interests focus on severe acute respiratory infection (SARI) pathogenesis, epidemiology, and their interaction with the coagulation system.
Some of Goeijenbier’s most published articles include:
- Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism
- Determinants of vaccination uptake in risk populations: A comprehensive literature review.
- Benefits of flu vaccination for persons with diabetes mellitus.
- Early Patient-Triggered Pressure Support Breathing in Mechanically Ventilated Patients with COVID-19 May Be Associated with Lower Rates of Acute Kidney Injury
Dr. Goeijenbier is ESWI’s lead member and Chair in the Influenza Diabetes Community (IDC). The IDC connects leading diabetes, patient, scientific, and professional organizations around the common aim of protecting persons living with diabetes from influenza and other viral respiratory diseases like COVID-19.
Starting January 2023, Dr. Goeijenbier has taken on the role of Chair of Medical Research and Education at Spaarne Hospital. Furthermore, since January 2024, Marco is the Editor in Chief for Nature Springer Tropical Diseases, Travel Medicine, and Vaccines.
